Celgene
| Type | Subsidiary |
|---|---|
| Industry | Biotechnology |
| Founded | 1986 (1986) |
| Founder | Sol J. Barer |
| Headquarters | Summit, New Jersey, U.S. |
| Key people | Robert J. Hugin (Executive Chairman) Mark Alles (CEO) |
| Products | Revlimid Abraxane Pomalyst/Imnovid Thalomid Idhifa |
| Revenue |  $15.281 billion (2018) |
| Net income | $4.046 billion (2018) |
| Total assets | $35.480 billion (2018) |
| Total equity |  $6.161 billion (2018) |
| Number of employees | 8,852 (2018) |
| Parent | Bristol Myers Squibb |
| Website | www.bms.com |
Celgene Corporation is a pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid (lenalidomide), which is used in the treatment of multiple myeloma, and also in certain anemias. The company is incorporated in Delaware, headquartered in Summit, New Jersey, and a subsidiary of Bristol Myers Squibb (BMS).
For detailed contact information visit location pages below.
Celgene's locations around the world
Clinical Trials sponsored by Celgene
-
CelgeneCelgene CorporationCompletatoGlioma | Tumore solido | Linfoma angioimmunoblastico a cellule T | Condrosarcoma | Colangiocarcinoma intraepaticoStati Uniti, Francia
-
CelgeneCelgene CorporationTerminatoTumori solidi avanzatiStati Uniti
-
CelgeneCelgene CorporationCompletatoMieloma multiplo | Mieloma multiplo refrattario | Mieloma multiplo in recidivaStati Uniti, Australia
-
Celgene CorporationCompletatoMieloma multiploStati Uniti, Spagna, Australia, Canada, Regno Unito, Italia, Svizzera, Bulgaria, Polonia, Ucraina, Belgio, Germania, Ungheria, Irlanda, Israele, Federazione Russa
-
Celgene CorporationTerminato
-
Celgene CorporationCompletatoMieloma multiplo recidivato o refrattarioGermania
-
Celgene CorporationTerminatoLinfoma diffuso a grandi cellule BStati Uniti, Canada, Australia
-
Celgene CorporationCompletatoSindrome dolorosa regionale complessa (RSD)Stati Uniti
-
Celgene CorporationCompletatoGlioblastoma | Gliomi maligniStati Uniti
-
CelgeneCelgene CorporationCompletatoLinfoma cutaneo a cellule TStati Uniti, Francia, Germania, Polonia, Federazione Russa, Regno Unito